| Can't view this email? Click here to view in your browser. | | | | Volume 480 Number 7377 | | | nature | | The science that matters. Every week. | | | | | | |
| | |
| Jump to the content that matters to you | | | | |
| | | | | Nationalize the Fukushima Daiichi atomic plant | How Japan deals with the radioactive and political fallout from the natural disasters of March 2011 that wrecked the Fukushima-Daiichi atomic plant will have immense implications for the nuclear power industry worldwide. In a Commentary piece this week, two prominent Japanese politicians, Tomoyuki Taira and Yukio Hatoyama, call for the nationalization of the plant as part of the recovery process. | | | | | | | | | Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 | The atomic-level structure of the V1/V2 variable region of gp120 envelope glycoprotein of HIV has been determined using an antibody called PG9, capable of neutralizing most strains of HIV. Instead of being confounded by the N-linked glycan that shields most of gp120 from immune recognition, PG9 uses it for binding via a mechanism shared by a number of antibodies capable of effective HIV neutralization. | | | | | | | | | Supernova SN 2011fe from an exploding carbon–oxygen white dwarf star | Supernova 2011fe in the Pinwheel galaxy, discovered by the Palomar Transient Factory on 24 August 2011, is the brightest type Ia supernova seen from Earth for many years. These observations, some of the earliest ever made on a type Ia supernova, suggest that the exploding star was probably a carbon-oxygen white dwarf, and its companion a main sequence star. | | | | | | | | | | | | | | | RNA-Seq just went from complicated to compatible. EA will provide your data in a format you are used to -- 100% microarray compatible format. Now you can have your data and use it too! Expression Analysis will help you detect 2x more differentially expressed transcripts, novel isoforms and SNVs and can achieve >97% alignment to your reference genome. 919-405-2248 | | | | | | | | | | | | | | | In this week's podcast: The elusive Higgs, a nearby supernova goes bang, a worrying ruling for stem cell research in Europe and why the Mediterranean went through a dry patch. | | | | | | | Specials - Outlook: Multiple Myeloma | | | | Despite a rash of new drugs and advances in stem-cell therapy, this rare, bloodborne cancer is still an almost certain death sentence. Although a cure remains a long way off, studies of multiple myeloma are yielding insights into bone biology, the role of the tumour microenvironment and the origins of a whole range of different cancers. ▼ more | | | | | | |
| | | | | | | | | | | | | | | | | Critical mass ▶ | | | Even Japan's political leaders struggle to get answers regarding the Fukushima disaster. It is just the latest example of the government's lack of independent scientific advice. | | | | | | | | Error of judgment ▶ | | | The European Court of Justice was wrong to weigh in on the definition of a human embryo. | | | | | | | | The mask slips ▶ | | | The Durban meeting shows that climate policy and climate science inhabit parallel worlds. | | | | | | | | | | | | | | | | | Seven days: 9–15 December 2011 ▶ | | | The week in science: boost for gene therapy; EPA reports concern over fracking; and a fresh clue to ancient water on Mars. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Astronomy in South Africa: The long shot ▶ | | | South Africa is vying fiercely with Australia to host a giant radio telescope that may never be built — but the competition itself is changing the country's science landscape. | | | | | | | | Stem cells: The cell division ▶ | | | Oliver Brüstle fought for more than a decade to pursue and patent human embryonic stem-cell research in Germany. Now his efforts have backfired. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | $3 million available now for innovative research funding Submit proposals now for projects focused in the following areas: - Development of therapeutics that target specific B cell lineages involved in MS pathology - Identification of surrogate or endogenous ligands for Orphan G Protein-Coupled Receptors (GPCRs) expressed exclusively or primarily in the central nervous system (CNS) that relate to the pathology of MS. Apply TODAY at www.fastforward.org | | | | | | | | |
| | | | | | | | |
| | | | | | | Introducing the Omni5 The latest Illumina® Omni microarray offers unprecedented coverage of variants from the International HapMap and 1000 Genomes projects. Plus, you can customize with content from your own sequencing studies. HumanOmni5-Quad BeadChip enables you to target genetic variation down to 1% minor allele frequency, and to identify structural variants using nearly 5,000 indel and multibase substitution markers. | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Jamming by shear ▶ | | | Dapeng Bi, Jie Zhang, Bulbul Chakraborty & R. P. Behringer | | | A broad class of disordered materials including foams, glassy molecular systems,... | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Diagnostics: The early bird ▶ | | | Identifying the patients most likely to progress from a precancerous condition to multiple myeloma could help doctors catch the disease early and stop it taking hold. | | | | | | | | | | | Drugs: More shots on target ▶ | | | Drugs introduced to fight multiple myeloma in the past decade have revolutionized treatment and extended patients' lives. Are the improvements set to continue? | | | | | | | | | | | Stem cells: Transplants on trial ▶ | | | Stem-cell transplants are an important tool for treating myeloma. But with improved drug alternatives, doctors disagree about the best time to give the treatment. | | | | | | | | | | | | | | | | | Aetiology: The path to disease ▶ | | | Multiple myeloma begins with a benign condition before progression to full-blown cancer, and work is underway to uncover the origins of both. | | | | | | | | | | | | | | | | | |
| | |
|
| | | | | | | | | Research: Radical rethink ▶ | | | Student-initiated projects have the potential to change a lab's focus. But with freedom comes responsibility. | | | | | | | | | | | Turning point: Jimmy Lin ▶ | | | Computational geneticist takes time away from academic pursuits to help kids with rare diseases. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Careers related news & comment | | | | | | | | | | | | |
| | | naturejobs.com Science jobs of the week | | | | | | | | | | | | | | | No matter what your career stage, student, postdoc or senior scientist, you will find articles on naturejobs.com to help guide you in your science career. Keep up-to-date with the latest sector trends, vote in our reader poll and sign-up to receive the monthly Naturejobs newsletter. | | | | | | | • Nature events featured events | | | | | | natureevents featured events | | | | | | | Nature events is the premier resource for scientists looking for the latest scientific conferences, courses, meetings and symposia. Featured across Nature Publishing Group journals and centrally at natureevents.com it is an essential reference guide to scientific events worldwide. | | | | |
| | | | | | | Extremes ▶ | | | Rachel Swirsky | | | Living on the edge.... | | | | | | | | | | Your email address is in the Nature mailing list. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact subscriptions@nature.com For other enquiries, please contact feedback@nature.com | Nature Publishing Group | 75 Varick Street, 9th floor | New York | NY 10013-1917 | USA
Nature Publishing Group's offices: Principal offices: London - New York - Tokyo Worldwide offices: Basingstoke - Boston - Buenos Aires - Delhi - Hong Kong - Madrid - Melbourne - Munich - Paris - San Francisco - Seoul - Washington DC
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | |
No comments:
Post a Comment